enVVeno Medical Corporati... (NVNO)
NASDAQ: NVNO
· Real-Time Price · USD
0.79
0.01 (1.26%)
At close: Sep 04, 2025, 3:59 PM
0.78
-1.14%
After-hours: Sep 04, 2025, 07:06 PM EDT
1.26% (1D)
| Bid | 0.77 |
| Market Cap | 15.18M |
| Revenue (ttm) | 812K |
| Net Income (ttm) | -23.07M |
| EPS (ttm) | -1.2 |
| PE Ratio (ttm) | -0.66 |
| Forward PE | -0.81 |
| Analyst | n/a |
| Ask | 0.8 |
| Volume | 601,627 |
| Avg. Volume (20D) | 768,853 |
| Open | 0.79 |
| Previous Close | 0.78 |
| Day's Range | 0.76 - 0.80 |
| 52-Week Range | 0.76 - 5.70 |
| Beta | 1.01 |
About NVNO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVNO
Website n/a
2 weeks ago
-17.09%
EnVVeno Medical shares are trading lower after the...
Unlock content with
Pro Subscription
2 weeks ago
-72.08%
EnVVeno Medical shares are trading lower after the company announced the FDA has not approved its VenoValve PMA submission.
2 weeks ago · accessnewswire.com
enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R)IRVINE, CA / ACCESS Newswire / August 20, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous diseas...
1 month ago · accessnewswire.com
enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update- Cash burn of $3.8 million in Q2 remains in line with projected quarterly range - Cash and investments are sufficient to fund operations through Q3'2026 at current cash burn rate - Commercial readine...
